Search

Your search keyword '"Bogaty P"' showing total 353 results

Search Constraints

Start Over You searched for: Author "Bogaty P" Remove constraint Author: "Bogaty P"
353 results on '"Bogaty P"'

Search Results

1. Gromov-Hausdorff class: its completeness and cloud geometry

2. On the experience of integrating scientific and educational institutions in projects to limit anthropogenic impact on near-Earth space

3. The CanMEDS Competency Framework in laboratory medicine: a phenomenographic study exploring how professional roles are applied outside the clinical environment

4. Routine invasive management after fibrinolysis in patients with ST-elevation myocardial infarction: a systematic review of randomized clinical trials

5. Acute ischemic heart disease and interventional cardiology: a time for pause

7. Workforce Training: The Pellissippi State Model.

10. CCS/CAR/CANM/CNCS/CanSCMR joint position statement on advanced noninvasive cardiac imaging using positron emission tomography, magnetic resonance imaging and multidetector computed tomographic angiography in the diagnosis and evaluation of ischemic heart disease – executive summary

12. STRENGTHS AND LIMITATIONS OF USING MEDICO-ADMINISTRATIVE DATA TO COMPARE THE PRACTICE AND OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION IN QUÉBEC WITH THE REST OF CANADA

14. Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events A GENIUS-CHD Study of Individual Participant Data

15. Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events

16. Subsequent Event Risk in Individuals With Established Coronary Heart Disease

18. Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects

19. MYOCARDIAL INFARCTION WITH LEFT BUNDLE BRANCH BLOCK: A DEADLY DISEASE WITH A LOW RATE OF REPERFUSION TREATMENT

20. PORTRAIT OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR REPLACEMENT IN QUÉBEC: A SYSTEMATIC FIELD EVALUATION

21. TRANSCATHETER AORTIC VALVE IMPLANTATION IN QUÉBEC: 4 YEARS OF COMPREHENSIVE EVALUATION AND RELATION TO QUALITY INDICATORS

22. EVOLUTION IN THE USE OF LONG-TERM LEFT VENTRICULAR ASSIST DEVICES IN QUÉBEC: 2010-12 VERSUS 2013-15 AND COMPARISON WITH THE INTERMACS REGISTRY

23. A COMPARISON OF QUALITY OF CARE OF PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION BY CHOICE OF REPERFUSION STRATEGY: RESULTS OF A QUÉBEC-WIDE, SYSTEMATIC FIELD EVALUATION (2013-14)

24. EVALUATION OF TRANSCATHETER AORTIC VALVE IMPLANTATION IN QUÉBEC USING NEWLY-ESTABLISHED CANADIAN CARDIOVASCULAR SOCIETY QUALITY INDICATORS

25. Variability in High-Sensitivity Cardiac Troponin T Testing in Stable Patients With and Without Coronary Artery Disease

27. PRIMARY ANGIOPLASTY TREATMENT DELAYS AFTER THE IMPLEMENTATION OF A PROVINCE-WIDE PREHOSPITAL ECG PROGRAM

28. USE AND OUTCOMES OF TRANSCATHETER AORTIC VALVE IMPLANTATION: RESULTS OF A QUÉBEC-WIDE FIELD EVALUATION

29. TREATMENT DELAYS ON HOURS VERSUS OFF HOURS IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION ACROSS ALL HOSPITALS PERFORMING PRIMARY ANGIOPLASTY IN QUÉBEC, CANADA: RESULTS OF A THIRD FIELD EVALUATION

30. WHAT ARE THE BEST INDICATORS OF THE PERFORMANCE OF TRANSCATHETER AORTIC VALVE IMPLANTATION? MEASURES OF QUALITY IN QUÉBEC COMPARED WITH INTERNATIONAL REGISTRIES

33. [Untitled]

34. Trends in the use of laboratory tests for the diagnosis of Clostridium difficile infection and association with incidence rates in Quebec, Canada, 2010-2014.

36. WHAT KINDS OF PATIENTS WITH CORONARY ARTERY DISEASE ARE TREATED WITH MULTIVESSEL PERCUTANEOUS INTERVENTION VERSUS BYPASS SURGERY? A PROVINCE-WIDE FIELD EVALUATION IN QUÉBEC HOSPITALS WITH ON-SITE CARDIAC SURGERY

37. CHARACTERISTICS OF PATIENTS WITH CORONARY ARTERY DISEASE TREATED WITH MULTIVESSEL PERCUTANEOUS CORONARY INTERVENTION IN HOSPITALS WITH AND WITHOUT ON-SITE CARDIAC SURGERY IN QUÉBEC: A PROVINCE-WIDE FIELD EVALUATION

38. USE AND OUTCOMES OF TRANSCATHETER AORTIC VALVE IMPLANTATION: Results OF A QUÉBEC-WIDE FIELD EVALUATION AND COMPARISON WITH THE TVT REGISTRY

40. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction

41. The delay to thrombolysis: an analysis of patient and hospital characteristics

49. 727 A Comparison of Outcomes of Patients with ST-Elevation Myocardial Infarction by Type of Hospital and Choice of Treatment: Results of a Québec-Wide, Systematic Field Evaluation (2008-2009)

Catalog

Books, media, physical & digital resources